Linezolid injection
Products billed under this code include Linezolid, Zyvox.
Payment limit per 200 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Linezolid, Zyvox.
Payment limit per 200 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Linezolid | Hikma Pharmaceuticals USA Inc. | 00143-9534-10 | 30 | $72.93 |
| Linezolid | Sandoz Inc. | 00781-3433-95 | 30 | $72.93 |
| Linezolid | Sagent Pharmaceuticals | 25021-0169-87 | 30 | $72.93 |
| Linezolid | Eugia US LLC | 55150-0242-51 | 30 | $72.93 |
| Linezolid | Caraco Pharmaceutical Laboratories LTD. | 57664-0683-57 | 30 | $72.93 |
| Linezolid | FreseniUS Kabi USA, LLC | 63323-0713-13 | 30 | $72.93 |
| Linezolid | Piramal Critical Care Inc | 66794-0219-43 | 30 | $72.93 |
| Linezolid | Piramal Critical Care Inc | 66794-0236-43 | 30 | $72.93 |
| Zyvox | Pfizer Inc | 00009-5137-04 | 10 | $24.31 |
| Zyvox | Pfizer Inc | 00009-5140-04 | 30 | $72.93 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Zyvox | Pfizer Inc | 00009-7807-02 | 30 | $72.93 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.431 | +$0.163 | 200 MG | Linezolid injection | v1, posted September 17, 2026 |
| 3Q26 | $2.268 | −$0.215 | 200 MG | Linezolid injection | v1, posted September 15, 2026 |
| 2Q26 | $2.483 | −$0.259 | 200 MG | Linezolid injection | v1, posted September 15, 2026 |
| 1Q26 | $2.742 | −$0.829 | 200 MG | Linezolid injection | v1, posted September 15, 2026 |
| 4Q25 | $3.571 | +$0.101 | 200 MG | Linezolid injection | v1, posted September 8, 2026 |
| 3Q25 | $3.47 | −$0.002 | 200 MG | Linezolid injection | v1, posted March 10, 2026 |
| 2Q25 | $3.472 | +$0.493 | 200 MG | Linezolid injection | v1, posted March 10, 2026 |
| 1Q25 | $2.979 | −$0.101 | 200 MG | Linezolid injection | v1, posted December 19, 2025 |
| 4Q24 | $3.08 | +$0.459 | 200 MG | Linezolid injection | v1, posted June 11, 2025 |
| 3Q24 | $2.621 | −$1.001 | 200 MG | Linezolid injection | v1, posted June 11, 2025 |
| 2Q24 | $3.622 | +$0.324 | 200 MG | Linezolid injection | v1, posted March 11, 2025 |
| 1Q24 | $3.298 | −$0.35 | 200 MG | Linezolid injection | v1, posted December 19, 2024 |
| 4Q23 | $3.648 | +$0.177 | 200 MG | Linezolid injection | v1, posted October 10, 2024 |
| 3Q23 | $3.471 | +$0.046 | 200 MG | Linezolid injection | v1, posted June 5, 2024 |
| 2Q23 | $3.425 | +$0.192 | 200 MG | Linezolid injection | v1, posted February 23, 2024 |
| 1Q23 | $3.233 | −$0.953 | 200 MG | Linezolid injection | v1, posted December 6, 2023 |
| 4Q22 | $4.186 | −$0.669 | 200 MG | Linezolid injection | v1, posted June 22, 2023 |
| 3Q22 | $4.855 | −$1.015 | 200 MG | Linezolid injection | v1, posted June 9, 2023 |
| 2Q22 | $5.87 | −$0.381 | 200 MG | Linezolid injection | v1, posted December 14, 2022 |
| 1Q22 | $6.251 | −$0.372 | 200 MG | Linezolid injection | v1, posted June 8, 2022 |
| 4Q21 | $6.623 | −$0.771 | 200 MG | Linezolid injection | v1, posted June 2, 2022 |
| 3Q21 | $7.394 | −$0.125 | 200 MG | Linezolid injection | v1, posted June 2, 2022 |
| 2Q21 | $7.519 | +$0.45 | 200 MG | Linezolid injection | v1, posted March 1, 2022 |
| 1Q21 | $7.069 | – | 200 MG | Linezolid injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.